Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma

Table 1 Clinical characteristics of patients in entire cohort, training cohort and validation cohort

Variables	Entire cohort (n = 502)		Training cohort (n = 334)		Validation cohort (n = 168)		p-value
Variables	No	%	No	%	No	%	p-value
Age
Median(years)	46	–	46	–	46	–	–
< 55	335	66.7	224	67.1	111	66.1	0.823
≥ 55	167	33.3	110	32.9	57	33.9
Gender
Female	367	73.1	248	74.3	119	70.8	0.41
Male	135	26.9	86	25.7	49	29.2
AJCC Stage							0.09
I	396	78.9	269	80.5	127	75.6
II	84	16.7	46	13.8	38	22.6
III	17	3.4	16	4.8	1	0.6
IV	5	1	3	0.9	2	1.2
T Stage							0.61
T1	145	28.9	94	28.1	51	30.4
T2	164	32.7	111	33.2	53	31.5
T3	170	33.9	111	33.2	59	35.1
T4	23	4.6	18	5.4	5	3
N Stage							0.207
N0	229	45.6	147	44	82	48.8
N1	223	44.4	155	46.4	68	40.5
Nx	50	10	32	9.6	18	10.7
M Stage							0.471
M0	282	56.2	188	56.3	94	56
M1	9	1.8	5	1.5	4	2.4
Mx	211	42	141	42.2	70	41.6

ISSN: 1475-2867